These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 29406567

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Safety and Tolerability of Nafamostat Mesilate and Heparin as Anticoagulants in Leukocytapheresis for Ulcerative Colitis: Post Hoc Analysis of a Large-Scale, Prospective, Observational Study.
    Sawada K, Ohdo M, Ino T, Nakamura T, Numata T, Shibata H, Sakou J, Kusada M, Hibi T.
    Ther Apher Dial; 2016 Apr; 20(2):197-204. PubMed ID: 26771066
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Univariate analysis to examine predictors of response to leukocytapheresis in ulcerative colitis patients.
    Nagayama K, Takedatsu H, Mitsuyama K, Yamasaki H, Kuwaki K, Yoshioka S, Kobayashi T, Yamauchi R, Kakuma T, Sata M.
    Ther Apher Dial; 2014 Jun; 18(3):244-51. PubMed ID: 24965290
    [Abstract] [Full Text] [Related]

  • 6. A large-scale, prospective, observational study of leukocytapheresis for ulcerative colitis: treatment outcomes of 847 patients in clinical practice.
    Yokoyama Y, Matsuoka K, Kobayashi T, Sawada K, Fujiyoshi T, Ando T, Ohnishi Y, Ishida T, Oka M, Yamada M, Nakamura T, Ino T, Numata T, Aoki H, Sakou J, Kusada M, Maekawa T, Hibi T.
    J Crohns Colitis; 2014 Sep; 8(9):981-91. PubMed ID: 24556083
    [Abstract] [Full Text] [Related]

  • 7. A multicenter study of the efficacy and safety of leukocytapheresis therapy without concomitant systemic steroid treatment in patients with active ulcerative colitis.
    Ashida T, Kohgo Y, Munakata A, Noguchi M, Iizuka B, Endo Y, Hanai H, Yoshikawa T, Matsumoto T, Aoyama N, Matsui T, Mitsuyama K, Hibi T.
    Transfus Apher Sci; 2011 Apr; 44(2):113-7. PubMed ID: 21402309
    [Abstract] [Full Text] [Related]

  • 8. Steroid-sparing strategies in the management of ulcerative colitis: efficacy of leukocytapheresis.
    Shiraki M, Yamamoto T.
    World J Gastroenterol; 2012 Nov 07; 18(41):5833-8. PubMed ID: 23139598
    [Abstract] [Full Text] [Related]

  • 9. Relationship between ulcerative colitis patients treated with leukocytapheresis and ulcerative colitis-associated colorectal cancer.
    Kinugasa T, Akagi Y, Murotani K, Romeo K, Yoshida T, Ryu Y, Shiratuchi I, Shirouzu K.
    Anticancer Res; 2011 Jul 07; 31(7):2547-52. PubMed ID: 21873173
    [Abstract] [Full Text] [Related]

  • 10. Optimal apheresis treatment volume for the efficacy and safety of leukocytapheresis with Cellsorba in patients with active ulcerative colitis.
    Fukunaga K, Kamikozuru K, Yokoyama Y, Hida N, Ohda Y, Takeda N, Yoshida K, Iimuro M, Kikuyama R, Kato K, Nagase K, Nakamura S, Miwa H, Matsumoto T.
    J Clin Apher; 2011 Dec 07; 26(6):326-31. PubMed ID: 22083887
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Factors affecting short- and long-term effects of leukocyte removal therapy in active ulcerative colitis.
    Nakano R, Iwakiri R, Ikeda Y, Kishi T, Tsuruoka N, Shimoda R, Sakata Y, Yamaguchi K, Fujimoto K.
    J Gastroenterol Hepatol; 2013 Feb 07; 28(2):303-8. PubMed ID: 23339387
    [Abstract] [Full Text] [Related]

  • 13. Multicenter prospective study for clinical and endoscopic efficacies of leukocytapheresis therapy in patients with ulcerative colitis.
    Okuyama Y, Andoh A, Nishishita M, Fukunaga K, Kamikozuru K, Yokoyama Y, Ueno Y, Tanaka S, Kuge H, Yoshikawa S, Sugahara A, Anami E, Munetomo Y, Watanabe C, Fujiyama Y, Matsumoto T.
    Scand J Gastroenterol; 2013 Apr 07; 48(4):412-8. PubMed ID: 23356660
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. LEUKOCYTAPHERESIS IN THE MANAGEMENT OF SEVERE STEROID-DEPENDENT ULCERATIVE COLITIS.
    Krznarić Ž, Markoš P, Golubić Ćepulić B, Čuković-Čavka S, Domislović V, Bojanić I, Barišić A, Kekez D.
    Acta Clin Croat; 2019 Sep 07; 58(3):529-534. PubMed ID: 31969767
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Leukocytapheresis (LCAP) for management of fulminant ulcerative colitis with toxic megacolon.
    Sawada K, Egashira A, Ohnishi K, Fukunaga K, Kusaka T, Shimoyama T.
    Dig Dis Sci; 2005 Apr 07; 50(4):767-73. PubMed ID: 15844716
    [Abstract] [Full Text] [Related]

  • 19. A pilot study of leukocytapheresis efficacy with 1.5 liter blood processing volume in patients with ulcerative colitis.
    Shimada M, Iwase H, Tsuzuki T, Hirashima N, Kobayashi K, Hibino Y, Watanabe H, Ryuge N, Ando T, Goto H, Yagi Y, Tsujikawa T, Andoh A.
    Ther Apher Dial; 2008 Oct 07; 12(5):368-73. PubMed ID: 18937719
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.